期刊文献+

普伐他汀对非对称性二甲基精氨酸促血管平滑肌细胞增殖的影响 被引量:4

Effect of pravastatin on proliferation of vascular smooth muscle cells stimulated by asymmetric dimethylarginine
下载PDF
导出
摘要 目的 探讨非对称性二甲基精氨酸 (ADMA)对血管平滑肌细胞增殖的作用和普伐他汀对ADMA促平滑肌细胞增殖的影响及其机制。方法 用[3H]TdR掺入法和MTT比色法检测ADMA对培养的牛胸主动脉平滑肌细胞增殖作用的量效关系和时效关系 ,以及普伐他汀等药物对ADMA刺激平滑肌细胞增殖的影响。结果 用 30~ 30 0 μmol·L- 1ADMA分别孵育平滑肌细胞后 ,都明显增加血管平滑肌细胞DNA的合成 ,表现在 [3H]TdR掺入量由对照组的(6 38± 134)cpm增加到大剂量ADMA组的 (12 79±111)cpm。用 30 0 μmol·L- 1ADMA孵育细胞 2 4~ 96h呈时间依赖性地促进血管平滑肌细胞增殖 ,表现为 [3H]TdR掺入量随着时间的延长分别增加为对照组的 1.5 ,2 .7,4 .3和 5 .6倍。普伐他汀 (10 0 μmol·L- 1)可逆转ADMA所致的细胞DNA合成的增加 ,[3H]TdR掺入量由ADMA单独孵育组的 (6 10± 2 0 2 )cpm降低至普伐他汀处理组的 (35 6± 12 6 )cpm。此外 ,一氧化氮供体硝普钠和抗氧化剂吡咯烷二硫代氨基甲酸盐处理后也可逆转这种增加。MTT法测定细胞数也证明 ,30~ 30 0 μmol·L- 1普伐他汀呈剂量依赖性地对抗ADMA所致的平滑肌细胞增殖。结论ADMA可促进血管平滑肌细胞的增殖 ;普伐他汀对ADMA所诱导的平滑肌细胞增殖具有抑制作用 ;这两者均可能与细? AIM To investigate the effect of asymmetri c dimethylarginine (ADMA) on proliferation of vascular smooth muscle cells (VSMC s) and determine whether pravastatin(PT) inhibits the proliferation of VSMCs ind uced by ADMA. METHODS VSMCs from bovine thoracic aorta were inc ubated with different concentrations of ADMA (30-300 μmol·L -1) or treat ed with ADMA (300 μmol·L -1) for varied periods (24-96 h). [ 3H]T dR incorporation and MTT were used to evaluate proliferation of VSMCs after expo sure to ADMA and the effect of PT or other drugs on the ADMA-induced VSMCs prol i feration. RESULTS ADMA (30-300 μmol·L -1) increased the DNA synthesis of VSMCs, showing that the [ 3H]TdR incorporation increased fr om (638±134)cpm (control group) to (1128±342)cpm (300 μmol·L -1 ADMA-t reated group). Additionally, incubation of VSMCs with 300 μmol·L -1 ADMA for 24-96 h significantly stimulated the DNA synthesis of VSMCs in a time-d ependent manner. The amount of [ 3H]TdR incorporation into VSMCs was incr eased to 1.5-, 2.7-, 4.3-, and 5.6-fold of control group, respectively. PT(100 μmol·L -1) reversed the increase of DNA synthesis in VSMCs induced by ADMA,as expressed by the [ 3H]TdR incorporation into VSMCs d ecrease d from (610±202)cpm of ADMA-treated group to (356±126)cpm of PT-treated group. Moreover, the increase of DNA synthesis in VSMCs induced by ADMA was also significantly suppressed by treatment with sodium nitroprusside, a donor of NO, and pyrrolidine dithiocarbamate, an antioxidant. The results of MTT assay c onfirmed that PT (30-300 μmol·L -1) reduced the ADMA-induced proliferat ion of VSMCs in a concentration-dependent manner. CONCLUSION ADMA accelerates proliferation of VSMCs and PT inhibits ADMA-induced prolif eration of VSMCs, which may relate to the alterations of nitric oxide synthesis and superoxide anion production in VSMCs.
作者 郭征 熊燕
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2004年第6期421-426,共6页 Chinese Journal of Pharmacology and Toxicology
基金 国家自然科学基金资助项目 (30 2 715 0 7)~~
关键词 二甲基非对称性精氨酸 普伐他汀 血管平滑肌 细胞增殖 asymmetric dimethylarginine pravastatin vascular smooth muscle cell proliferation
  • 相关文献

参考文献22

  • 1McNamara CA, Sarembock IJ, Bachhuber BG, Stouffer GA, Ragosta M, Barry W, et al. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis[J]. Semin Thromb Hemost, 1996, 22(2):139-144.
  • 2Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis[J]. Circulation, 1999, 99(9):1141-1146.
  • 3Yu XJ, Li YJ, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits[J]. Life Sci, 1994, 54(12):753-758.
  • 4Boger RH, Bode-Boger SM, Sydow K, Heistad DD, Lentz SR. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia[J]. Arterioscler Thro
  • 5Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine(ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia[J]. Circulation, 1998, 98(18):1842-1847.
  • 6Kakimoto Y, Akazawa S. Isolation and identification of NG,NG- and NG,N′G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-δ-hydroxylysine from human urine[J]. J Biol Chem, 1970, 245(21):5751-5758.
  • 7Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, Mac Allister R, et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase[J]. Arterioscler Thromb Va
  • 8Masuda H, Goto M, Tamaoki S, Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia[J]. Br J Pharmacol, 1999, 126(1):211-218.
  • 9Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention[J]. Eur Heart J, 2003, 24(21):1912-1919.
  • 10Houghton JL, Pearson TA, Reed RG, Torosoff MT, Henches NL, Kuhner PA, et al. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms[J]. Chest, 2000, 118(3):756-760.

同被引文献30

  • 1王亮,张抒扬.新的血管内皮损伤标记物——非对称性二甲基精氨酸[J].中华临床医师杂志(电子版),2011,5(16):4795-4798. 被引量:11
  • 2Boger RH, Bode-Boger SM,Tsao PS, et al. An endogenous inhibitor of nitric oxide synthase endbthelial adhesiveness for monocytes [ J ]. J Am Coil Cardiol, 2000, 36 (7): 2287-2295.
  • 3Chan JR, Boger RH, Bode-Boger SM, et al. Asymmetric dimethylarginine increases mononuclear cell adhesive ness in hyperholesterolemic humans [ J]. Arterioseler Thromb Vase Biol, 2000,20(4) : 1040-1046.
  • 4Konukoglu D, Firtina S, Serin O. The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance[ J ]. Metabolism ,2008, 57 (1) : 110-115.
  • 5Jiang D J, Jiang JL, Tan GS, et al. Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level [ J ]. Planta Med,2003, 69(12) :1150-1152.
  • 6Chen MF, Xie XM, Yang TL, et al. Role of Asymmetric Dimethylarginine in Inflammatory Reactions by Angiotensin Ⅱ [J]. J Vasc Res,2007, 44 (5) :391-402.
  • 7Jiang JL, Wang S, Li NS, et al. The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells [ J ]. Biochem Cell Biol, 2007, 85 (1): 66-77.
  • 8Jia S J, Jiang DJ, Hu CP, et al. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells [ J ]. Vascul Pharmacol, 2006, 44(3) : 143-148.
  • 9Suda O, Tsutsui M, Morishita T, et al. Asymmetric dimethylarginine pro- duces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress [ J ]. Arterio- scler Thromb Vasc Biol, 2004, 24 (9) : 1682-1688.
  • 10Jiang D J, Jia S J, Dai Z, et al. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3- dependent signaling pathway in endothelial cells[ J]. J Mol Cell Cardiol, 2006, 40(4) :529-539.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部